Stay updated on Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page
- CheckyesterdayChange DetectedA new revision tag, Revision: v3.5.4, was added and the previous tag Revision: v3.5.3 was removed. This indicates a minor update to the page's revision history rather than a substantive content change.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays an updated ClinicalTrials.gov release/version identifier (“Revision: v3.5.3”) instead of the previous one (“v3.5.2”), with no other study-details text change shown.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the page header.SummaryDifference0.1%

- Check72 days agoChange DetectedPage revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1. This update is a UI/version label change and does not alter study content or functionality.SummaryDifference0.1%

Stay in the know with updates to Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.